CD274 and neoplasm: In addition, Ahmed et al. suggested that higher levels of PD-L1 expression in tumor cells, stromal immune cells, and co-localization of CD68-positive cells were strongly linked to superior pCR of NAC durvalumab in TNBC group (Ahmed et al., 2020).